Cargando…
Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds
In this paper, we aimed to exploit and combine in the same molecule the carbazole and the 1,3,4-oxadiazole pharmacophores, to obtain novel carprofen derivatives, by using two synthesis pathways. For the first route, the following steps have been followed: (i) (RS)-2-(6-chloro-9H-carbazol-2-yl)propan...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024163/ https://www.ncbi.nlm.nih.gov/pubmed/31936505 http://dx.doi.org/10.3390/molecules25020266 |
_version_ | 1783498371371106304 |
---|---|
author | Bordei Telehoiu, Alexandra T. Nuță, Diana C. Căproiu, Miron T. Dumitrascu, Florea Zarafu, Irina Ioniță, Petre Bădiceanu, Carmellina D. Avram, Speranța Chifiriuc, Mariana C. Bleotu, Coralia Limban, Carmen |
author_facet | Bordei Telehoiu, Alexandra T. Nuță, Diana C. Căproiu, Miron T. Dumitrascu, Florea Zarafu, Irina Ioniță, Petre Bădiceanu, Carmellina D. Avram, Speranța Chifiriuc, Mariana C. Bleotu, Coralia Limban, Carmen |
author_sort | Bordei Telehoiu, Alexandra T. |
collection | PubMed |
description | In this paper, we aimed to exploit and combine in the same molecule the carbazole and the 1,3,4-oxadiazole pharmacophores, to obtain novel carprofen derivatives, by using two synthesis pathways. For the first route, the following steps have been followed: (i) (RS)-2-(6-chloro-9H-carbazol-2-yl)propanonic acid (carprofen) treatment with methanol, yielding methyl (RS)-2-(6-chloro-9H-carbazol-2-yl)propanoate; (ii) the resulted methylic ester was converted to (RS)-2-(6-chloro-9H-carbazol-2-yl)propane hydrazide (carprofen hydrazide) by treatment with hydrazine hydrate; (iii) reaction of the hydrazide derivative with acyl chlorides led to N-[(2RS)-2-(6-chloro-9H-carbazol-2-yl)propanoil]-N′-R-substituted-benzoylhydrazine formation, which; (iv) in reaction with phosphorus oxychloride gave the (RS)-1-(6-chloro-9H-carbazol-2-yl)-1-(1,3,4-oxadiazol-2-yl)ethane derivatives. In the second synthesis pathway, new 1,3,4-oxadiazole ring compounds were obtained starting from carprofen which was reacted with isoniazid, in the presence of phosphorus oxychloride to form (RS)-1-(6-chloro-9H-carbazol-2-yl)-1-[5-(4-pyridyl)-1,3,4-oxadiazol-2-yl]ethane. The synthesized compounds were characterized by IR, (1)H-NMR and (13)C-NMR, screened for their drug-like properties and evaluated for in vitro cytotoxicity and antimicrobial activity. The obtained compounds exhibited a good antimicrobial activity, some of the compounds being particularly active on E. coli, while others on C. albicans. The most significant result is represented by their exceptional anti-biofilm activity, particularly against the P. aeruginosa biofilm. The cytotoxicity assay revealed that at concentrations lower than 100 μg/mL, the tested compounds do not induce cytotoxicity and do not alter the mammalian cell cycle. The new synthesized compounds show good drug-like properties. The ADME-Tox profiles indicate a good oral absorption and average permeability through the blood brain barrier. However, further research is needed to reduce the predicted mutagenic potential and the hepatotoxicity. |
format | Online Article Text |
id | pubmed-7024163 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70241632020-03-19 Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds Bordei Telehoiu, Alexandra T. Nuță, Diana C. Căproiu, Miron T. Dumitrascu, Florea Zarafu, Irina Ioniță, Petre Bădiceanu, Carmellina D. Avram, Speranța Chifiriuc, Mariana C. Bleotu, Coralia Limban, Carmen Molecules Article In this paper, we aimed to exploit and combine in the same molecule the carbazole and the 1,3,4-oxadiazole pharmacophores, to obtain novel carprofen derivatives, by using two synthesis pathways. For the first route, the following steps have been followed: (i) (RS)-2-(6-chloro-9H-carbazol-2-yl)propanonic acid (carprofen) treatment with methanol, yielding methyl (RS)-2-(6-chloro-9H-carbazol-2-yl)propanoate; (ii) the resulted methylic ester was converted to (RS)-2-(6-chloro-9H-carbazol-2-yl)propane hydrazide (carprofen hydrazide) by treatment with hydrazine hydrate; (iii) reaction of the hydrazide derivative with acyl chlorides led to N-[(2RS)-2-(6-chloro-9H-carbazol-2-yl)propanoil]-N′-R-substituted-benzoylhydrazine formation, which; (iv) in reaction with phosphorus oxychloride gave the (RS)-1-(6-chloro-9H-carbazol-2-yl)-1-(1,3,4-oxadiazol-2-yl)ethane derivatives. In the second synthesis pathway, new 1,3,4-oxadiazole ring compounds were obtained starting from carprofen which was reacted with isoniazid, in the presence of phosphorus oxychloride to form (RS)-1-(6-chloro-9H-carbazol-2-yl)-1-[5-(4-pyridyl)-1,3,4-oxadiazol-2-yl]ethane. The synthesized compounds were characterized by IR, (1)H-NMR and (13)C-NMR, screened for their drug-like properties and evaluated for in vitro cytotoxicity and antimicrobial activity. The obtained compounds exhibited a good antimicrobial activity, some of the compounds being particularly active on E. coli, while others on C. albicans. The most significant result is represented by their exceptional anti-biofilm activity, particularly against the P. aeruginosa biofilm. The cytotoxicity assay revealed that at concentrations lower than 100 μg/mL, the tested compounds do not induce cytotoxicity and do not alter the mammalian cell cycle. The new synthesized compounds show good drug-like properties. The ADME-Tox profiles indicate a good oral absorption and average permeability through the blood brain barrier. However, further research is needed to reduce the predicted mutagenic potential and the hepatotoxicity. MDPI 2020-01-09 /pmc/articles/PMC7024163/ /pubmed/31936505 http://dx.doi.org/10.3390/molecules25020266 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bordei Telehoiu, Alexandra T. Nuță, Diana C. Căproiu, Miron T. Dumitrascu, Florea Zarafu, Irina Ioniță, Petre Bădiceanu, Carmellina D. Avram, Speranța Chifiriuc, Mariana C. Bleotu, Coralia Limban, Carmen Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds |
title | Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds |
title_full | Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds |
title_fullStr | Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds |
title_full_unstemmed | Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds |
title_short | Design, Synthesis and In Vitro Characterization of Novel Antimicrobial Agents Based on 6-Chloro-9H-carbazol Derivatives and 1,3,4-Oxadiazole Scaffolds |
title_sort | design, synthesis and in vitro characterization of novel antimicrobial agents based on 6-chloro-9h-carbazol derivatives and 1,3,4-oxadiazole scaffolds |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7024163/ https://www.ncbi.nlm.nih.gov/pubmed/31936505 http://dx.doi.org/10.3390/molecules25020266 |
work_keys_str_mv | AT bordeitelehoiualexandrat designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT nutadianac designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT caproiumiront designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT dumitrascuflorea designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT zarafuirina designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT ionitapetre designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT badiceanucarmellinad designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT avramsperanta designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT chifiriucmarianac designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT bleotucoralia designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds AT limbancarmen designsynthesisandinvitrocharacterizationofnovelantimicrobialagentsbasedon6chloro9hcarbazolderivativesand134oxadiazolescaffolds |